Quantcast

Latest Tyrosine kinase inhibitors Stories

2015-05-04 08:30:30

New Studies Identify Molecular Target, Mitochondria-Specific Effects of ME-344; Results from First-in-Human Clinical Study Published in Cancer SAN DIEGO, May 4, 2015 /PRNewswire/ --

2015-03-12 12:30:14

AUSTIN, Texas, March 12, 2015 /PRNewswire/ -- XBiotech announced today that it has launched a website and call center to help patients with metastatic colorectal cancer learn about its U.S.

2015-01-05 08:29:52

NEW YORK, Jan. 5, 2015 /PRNewswire/ -- Exelixis, Inc. (NASDAQ: EXEL) is a biotechnology company that develops and markets treatments for cancer.

2014-12-25 23:00:21

RnRMarketResearch.com adds “Nintedanib (Colorectal Cancer) – Forecast and Market Analysis to 2023” to its store.

2014-10-29 08:33:36

MTD Confirmed in Combination with Topotecan, First Patient Dosed in Cohort Expansion SAN DIEGO, Oct. 29, 2014 /PRNewswire/ -- MEI Pharma, Inc.

2014-07-17 16:26:09

NEW YORK, July 17, 2014 /PRNewswire/ -- Exelixis, Inc. (Nasdaq: EXEL) is a development stage biotech company.

2014-05-15 08:31:37

ROCKVILLE, Md., May 15, 2014 /PRNewswire/ -- EntreMed, Inc.


Word of the Day
begunk
  • To befool; deceive; balk; jilt.
  • An illusion; a trick; a cheat.
The word 'begunk' may come from a nasalised variant of Scots begeck ("to deceive, disappoint"), equivalent to be- +‎ geck.